
Moderna's CEO told The Wall Street Journal that his cancer vaccine's data will get better with time, and that no one can easily copy the company's work
来源:WSJ发布于 2026-10-28
Stéphane Bancel defended his melanoma data and argued that rivals can't easily copy the technology.
相关标的:MRNA
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。